NO912271L - Somatostatinpreparater, deres fremstilling og anvendelse. - Google Patents

Somatostatinpreparater, deres fremstilling og anvendelse.

Info

Publication number
NO912271L
NO912271L NO91912271A NO912271A NO912271L NO 912271 L NO912271 L NO 912271L NO 91912271 A NO91912271 A NO 91912271A NO 912271 A NO912271 A NO 912271A NO 912271 L NO912271 L NO 912271L
Authority
NO
Norway
Prior art keywords
somatostatin
preparation
preparations
psycholic
ursodeoxy
Prior art date
Application number
NO91912271A
Other languages
English (en)
Norwegian (no)
Other versions
NO912271D0 (no
Inventor
Gerd Fricker
Jacky Vonderscher
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of NO912271D0 publication Critical patent/NO912271D0/no
Publication of NO912271L publication Critical patent/NO912271L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/31—Somatostatins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO91912271A 1990-06-15 1991-06-13 Somatostatinpreparater, deres fremstilling og anvendelse. NO912271L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909013448A GB9013448D0 (en) 1990-06-15 1990-06-15 Pharmaceutical resorption-improved somatostatin compositions,their preparation and use

Publications (2)

Publication Number Publication Date
NO912271D0 NO912271D0 (no) 1991-06-13
NO912271L true NO912271L (no) 1991-12-16

Family

ID=10677720

Family Applications (1)

Application Number Title Priority Date Filing Date
NO91912271A NO912271L (no) 1990-06-15 1991-06-13 Somatostatinpreparater, deres fremstilling og anvendelse.

Country Status (21)

Country Link
EP (1) EP0462071B1 (de)
JP (1) JPH04230223A (de)
KR (1) KR920000323A (de)
AU (1) AU7833191A (de)
CA (1) CA2044511A1 (de)
CH (1) CH683069A5 (de)
DE (1) DE4119062A1 (de)
ES (1) ES2067906T3 (de)
FI (1) FI912868L (de)
FR (1) FR2663227B1 (de)
GB (2) GB9013448D0 (de)
HU (1) HUT59007A (de)
IE (1) IE912010A1 (de)
IL (1) IL98477A0 (de)
IT (1) IT1297205B1 (de)
LU (1) LU87952A1 (de)
NO (1) NO912271L (de)
NZ (1) NZ238522A (de)
PT (1) PT97964A (de)
TW (1) TW226332B (de)
ZA (1) ZA914583B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9203769D0 (en) * 1992-02-21 1992-04-08 Sandoz Ltd Improvements in or relating to organic compounds
DE69430295T2 (de) * 1993-07-30 2002-10-31 Teijin Ltd., Osaka Pulver zur nasalen Verabreichung peptidischer oder proteinischer Arzneistoffe
GB9417524D0 (en) * 1994-08-31 1994-10-19 Cortecs Ltd Pharmaceutical compositions
JPH11292787A (ja) * 1995-08-15 1999-10-26 Asahi Chem Ind Co Ltd 生理活性ペプチドを含有する経粘膜投与製剤
AR028023A1 (es) * 2000-04-19 2003-04-23 Borody Thomas J Una composicion farmaceutica para el tratamiento de la hiperlipidemia y el uso de dicha composicion para la preparacion de medicamentos
US20030083241A1 (en) * 2001-11-01 2003-05-01 Young Charles W. Use of somatostatin receptor agonists in the treatment of human disorders of sleep hypoxia and oxygen deprivation
PT2275103E (pt) 2005-11-21 2014-07-24 Novartis Ag Inibidores de mtor para o tratamento de tumores endócrinos
EP1959982B1 (de) * 2005-12-01 2012-08-08 Flinders Technologies PTY. Ltd. Verfahren und zusammensetzungen zur prävention und/oder behandlung von pankreatitis
RU2678833C2 (ru) 2008-09-17 2019-02-04 Киазма Инк. Фармацевтические композиции и соответствующие способы доставки
GB0817969D0 (en) * 2008-10-01 2008-11-05 Axcess Ltd Pharmaceutical composition
SI3253401T1 (sl) 2015-02-03 2025-07-31 Amryt Endo, Inc. Zdravljenje akromegalije z oralnim oktreotidom
US11141457B1 (en) 2020-12-28 2021-10-12 Amryt Endo, Inc. Oral octreotide therapy and contraceptive methods

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL68769A (en) * 1983-05-23 1986-02-28 Hadassah Med Org Pharmaceutical compositions containing insulin for oral administration
NL8701143A (nl) * 1986-05-27 1987-12-16 Sandoz Ag Farmaceutische preparaten.
JPS632932A (ja) * 1986-06-23 1988-01-07 Teijin Ltd 経鼻投与用粉末状組成物
HU203204B (en) * 1987-09-15 1991-06-28 Sandoz Ag Process for producing suppository containing calcitonin and taurocholic acid

Also Published As

Publication number Publication date
GB2244918B (en) 1994-06-15
AU7833191A (en) 1992-01-02
FI912868A7 (fi) 1991-12-16
FI912868A0 (fi) 1991-06-13
KR920000323A (ko) 1992-01-29
ITRM910430A0 (it) 1991-06-17
ZA914583B (en) 1993-02-24
FI912868L (fi) 1991-12-16
IE912010A1 (en) 1991-12-18
PT97964A (pt) 1992-03-31
ES2067906T3 (es) 1995-04-01
CA2044511A1 (en) 1991-12-16
HUT59007A (en) 1992-04-28
FR2663227B1 (fr) 1995-04-28
GB2244918A (en) 1991-12-18
FR2663227A1 (fr) 1991-12-20
EP0462071B1 (de) 1995-02-01
LU87952A1 (fr) 1993-01-15
NO912271D0 (no) 1991-06-13
CH683069A5 (de) 1994-01-14
EP0462071A1 (de) 1991-12-18
TW226332B (de) 1994-07-11
HU911849D0 (en) 1991-12-30
JPH04230223A (ja) 1992-08-19
GB9112509D0 (en) 1991-07-31
DE4119062A1 (de) 1991-12-19
IL98477A0 (en) 1992-07-15
GB9013448D0 (en) 1990-08-08
NZ238522A (en) 1993-10-26
IT1297205B1 (it) 1999-08-03
ITRM910430A1 (it) 1992-12-17

Similar Documents

Publication Publication Date Title
NO933434D0 (no) Piperidinderivater, deres fremstilling og anvendelse
DK132789D0 (da) 9-halogen-(z)-prostaglandinderivater, fremgangsmaade til deres fremstilling og deres anvendelse som laegemiddel
FI935071A7 (fi) Uudet perhydroisoindolit, niiden valmistus ja niitä sisältävät farmase uttiset valmisteet
NO20064159L (no) Nye, biologisk aktive polypeptider, deres fremstilling og farmasoytiske preparater inneholdende polypeptidene
MX9203480A (es) Formulaciones medicinales en aereosol.
IT8619625A0 (it) Composizioni farmaceutiche per inalazione.
DE3868986D1 (de) Pharmazeutische zusammensetzungen.
DE69104777D1 (de) Orale Arzneimittelformen von biologisch aktiven Eiweisstoffen.
NO902658L (no) N-fenylpyrazolderivater, preparater og anvendelse derav.
IT8721411A0 (it) Composizione farmaceutica idrosolubile contenente n acetilsisteina.
DK0399902T3 (da) Porøs farmaceutisk tilberedningsform og fremstilling deraf
DK209188D0 (da) Bifunktionelle proteiner, deres fremstilling og anvendelse som laegemiddel
NL194749B (nl) Stabiel calciumhoudend farmaceutisch preparaat.
IT8721410A0 (it) Composizione farmaceutica idrosolubile contenente n acetilcisteina.
DE3882157D1 (de) Nichtsteroide antientzuendungswirkstoffe enthaltende pharmazeutische zubereitungen.
DK0482097T3 (da) Tensidpræparater og fremgangsmåder
NO893196D0 (no) Hybrid-protein-c-sammensetninger og fremgangsmaater for deres fremstilling.
ES2131528T3 (es) Nuevos polipeptidos y su uso.
NO912271D0 (no) Somatostatinpreparater, deres fremstilling og anvendelse.
DK34687A (da) Laegemiddel til nasal anvendelse, dets fremstilling og anvendelse
NO870965L (no) Aminosukkerkarboneringsmidler og deres fremstilling.
NO874193D0 (no) Farmasoeytiske preparater.
NO933435D0 (no) Piperidinderivater, deres fremstilling og anvendelse
NO900926D0 (no) Substituerte (kinolin-2-yl-metoksy)fenyl-n,n'-sulfonylurinstoffer, deres fremstilling og anvendelse i legemidler.
DK330687D0 (da) Forbindelser og farmaceutiske kompositioner, der er anvendelige som cardiotoniske midler